SU11248, a multi-targeted tyrosine kinase inhibitor, can overcome imatinib (IM) resistance caused by diverse genomic mechanisms in patients (pts) with metastatic gastrointestinal stromal tumor (GIST) Meeting Abstract
| Authors: | Demetri, G. D.; Desai, J.; Fletcher, J. A.; Morgan, J. A.; Fletcher, C. D. M.; Kazanovicz, A.; Van Den Abbeele, A.; Baum, C.; Maki, R.; Heinrich, M. C. |
| Abstract Title: | SU11248, a multi-targeted tyrosine kinase inhibitor, can overcome imatinib (IM) resistance caused by diverse genomic mechanisms in patients (pts) with metastatic gastrointestinal stromal tumor (GIST) |
| Meeting Title: | 40th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 22 |
| Issue: | 14 Suppl. |
| Meeting Dates: | 2004 Jun 5-8 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2004-07-15 |
| Start Page: | 195S |
| Language: | English |
| ACCESSION: | WOS:000223512400770 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2004.22.90140.3001 |
| Notes: | Meeting Abstract: 3001 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos |
